
Typhoid Outbreak: Genetic Cause of Extensive Drug-resistance Found
New Drug Hope for Rare Bone Cancer Patients
New Drug Hope For Rare Bone Cancer Patients
Patients with a rare bone cancer of the skull and spine – chordoma – could be helped by existing drugs, suggest scientists from the Wellcome Trust Sanger Institute, University College London Cancer Institute and the Royal National Orthopaedic Hospital NHS Trust. In the largest genomics study of chordoma to date, published today (12th October) in Nature…
Malaria Vaccine Target’s Invasion Partner Uncovered
Largest Genetic Study of Inflammatory Bowel Disease Provides Clues on New Drug Targets
Best Treatment Option Written in Cancer’s Genetic Script: AML Study Finds Personalized Therapy Is Possible
An international collaboration led by clinical researchers at the Wellcome Trust Sanger Institute has shown proof-of-concept that truly personalised therapy will be possible in the future for people with cancer. Details of how a knowledge bank could be used to find the best treatment option for people with acute myeloid leukaemia (AML) are published today…